(Q39953417)

15 September 2017

title

Advances in human clinical trials of vaccines to prevent HIV/AIDS and other HIV prevention interventions (English)

1 reference

15 September 2017

0 references

0 references

prevention of HIV/AIDS

0 references

1

Mark J Mulligan

1 reference

15 September 2017

publication date

1 September 2009

1 reference

Current infectious disease reports

15 September 2017

published in

1 reference

15 September 2017

volume

11

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

399-406

1 reference

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

15 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-009-0056-9

Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-009-0056-9

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

21 January 2018

1 reference

12 December 2020

Estimation of HIV incidence in the United States

1 reference

12 December 2020

HIV vaccine research: the way forward

1 reference

12 December 2020

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

1 reference

12 December 2020

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

1 reference

12 December 2020

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

1 reference

12 December 2020

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

1 reference

12 December 2020

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

1 reference

12 December 2020

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection

1 reference

12 December 2020

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

12 December 2020

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

1 reference

12 December 2020

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

12 December 2020

Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004

1 reference

12 December 2020

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

1 reference

12 December 2020

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

1 reference

12 December 2020

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

1 reference

12 December 2020

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

1 reference

12 December 2020

A chorus of disapproval

1 reference

12 December 2020

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

AIDS vaccine research. Thumbs down on expensive, hotly debated trial of NIH AIDS vaccine

1 reference

12 December 2020

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

1 reference

12 December 2020

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys

1 reference

12 December 2020

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

12 December 2020

10.1007/S11908-009-0056-9

Identifiers

DOI

1 reference

15 September 2017

1 reference